kabutan

Perseus Proteomics, The Current Fiscal Year's Undisclosed Net Income to Narrow

Tue Mar 31, 2026 3:30 pm JST Revision

4882 Perseus Proteomics Inc. 【J-GAAP】

Guidance Update Report

Perseus Proteomics Inc. <4882> [TSE Growth] announced a previously undisclosed earnings forecast after the market closed on March 31st (15:30). The net loss (non-consolidated) for the fiscal year ending March 2026 is expected to further decrease to loss of 758 million yen (compared to a loss of 904 million yen in the previous period).

Kabutan News

Guidance Update

Second Half Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2025 Prev ー ー ー ー － 0 May 15, 2025 J-GAAP
Oct - Mar, 2025 New 75 -373 -362 -379 -25.4 0 Mar 31, 2026 J-GAAP
Revision Rate － － － － －

Full Year Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2026 Prev ー ー ー ー － 0 May 15, 2025 J-GAAP
Mar, 2026 New 135 -772 -707 -758 -50.9 0 Mar 31, 2026 J-GAAP
Revision Rate － － － － －

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2024 61 -412 -402 -409 -28.7 0 May 15, 2025 J-GAAP
Oct - Mar, 2025 Guidance 75 -373 -362 -379 -25.4 0 Mar 31, 2026 J-GAAP
YoY +23.0% +9.5% +10.0% +7.3% +11.3%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 100 -894 -879 -1,104 -93.7 0 May 15, 2024 J-GAAP
Mar, 2025 120 -826 -829 -904 -63.4 0 May 15, 2025 J-GAAP
Mar, 2026 Guidance 135 -772 -707 -758 -50.9 0 Mar 31, 2026 J-GAAP
YoY +12.5% +6.5% +14.7% +16.2% +19.8%

Related Articles